Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12089588 Reduction of erythrocyte sedimentation rate

Patent 12089588 was granted and assigned to Biomatrica on September, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Joel Desharnais0

Margrith Mattmann0

Victoria Arendt0

Date of Patent

September 17, 2024

0

Patent Application Number

174009310

Date Filed

August 12, 2021

0

Patent Citations

US Patent 6896894 Proteins stabilized with polysaccharide gums

0

US Patent 6919172 Preservation and storage medium for biological materials

0

US Patent 6942964 Tracer reagents that enhance reaction-product analysis

0

US Patent 6949544 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases

0

US Patent 6949547 Pyrazine based inhibitors of glycogen synthase kinase 3

0

US Patent 7001770 Calpain inhibitors and their applications

0

US Patent 7001905 Substituted diarylamines as MEK inhibitors

0

US Patent 6852833 Artificial chaperon kit

0

...

Patent Primary Examiner

Ekandra S. Miller-Cruz

0

CPC Code

0

0

0

0

0

Patent abstract

The present invention relates to reduction of erythrocyte sedimentation rate in a blood sample. In particular, formulations, compositions, articles of manufacture, kits and methods for reduced erythrocyte sedimentation rate in a blood sample are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12089588 Reduction of erythrocyte sedimentation rate

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool